Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-04 PET/CT for Oral Carcinoma
NCT05003427Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI-4 in oral carcinoma (OSCC), sponsored by Peking Union Medical College Hospital. Primary endpoints: Diagnostic performance1 at 1 year and Diagnostic performance2 at 1 year. Status: unknown.
02
Drugs
68Ga-FAPI-4
03
Conditions
oral carcinoma (OSCC)
Beyond the preview
Go deeper on NCT05003427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003427.